We are live on ! Find out more
GCP

GSA Capital Partners Portfolio holdings

AUM $1.61B
1-Year Est. Return 28.28%
This Fund
S&P 500
This Quarter Est. Return
-0.82%
1 Year Est. Return
+28.28%
3 Year Est. Return
+64.67%
5 Year Est. Return
+51.31%
10 Year Est. Return
+329.48%
AUM
$1.61B
AUM Growth
+$447M
Cap. Flow
+$533M
Cap. Flow %
33.15%
Top 10 Hldgs %
11.86%
Holding
2,259
New
642
Increased
549
Reduced
466
Closed
595

Top Sells

Rank Stock Value
1
EOG icon
EOG Resources
EOG
+$4.13M
2
NVDA icon
NVIDIA
NVDA
+$4.12M
3
PFE icon
Pfizer
PFE
+$4.01M
4
LNG icon
Cheniere Energy
LNG
+$3.83M
5
HOLX
Hologic
HOLX
+$3.1M

Sector Composition

Rank Sector Weight
1 Financials 13.44%
2 Technology 13.16%
3 Healthcare 12.56%
4 Industrials 12.44%
5 Consumer Discretionary 10.36%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
RC
1451
Ready Capital
RC
$265M
$204K 0.01%
125,927
-178,938
-59% -$342K
YSG
1452
Yatsen Holding
YSG
$318M
$204K 0.01%
66,325
+7,465
+13% +$30K
PPL
1453
PPL Corp
PPL
$27.1B
$203K 0.01%
+5,320
New +$196K
OPEN icon
1454
Opendoor
OPEN
$3.71B
$202K 0.01%
43,125
-173,368
-80% -$934K
REG icon
1455
Regency Centers
REG
$15.1B
$202K 0.01%
+2,676
New +$199K
ULTA icon
1456
Ulta Beauty
ULTA
$20.7B
$201K 0.01%
+384
New +$244K
CPSH icon
1457
CPS Technologies
CPSH
$76.7M
$199K 0.01%
53,120
+1,513
+3% +$6.7K
CRDF icon
1458
Cardiff Oncology
CRDF
$65M
$199K 0.01%
123,008
-87,872
-42% -$180K
GALT icon
1459
Galectin Therapeutics
GALT
$223M
$199K 0.01%
71,425
-30,541
-30% -$92.9K
BWEN icon
1460
Broadwind
BWEN
$112M
$198K 0.01%
95,390
+61,570
+182% +$167K
CNDT icon
1461
Conduent
CNDT
$234M
$197K 0.01%
154,101
+104,521
+211% +$159K
AXIA
1462
AXIA Energia
AXIA
$22.9B
$197K 0.01%
+17,457
New +$189K
ERIC icon
1463
Ericsson
ERIC
$31.8B
$197K 0.01%
+17,436
New +$189K
LXEO icon
1464
Lexeo Therapeutics
LXEO
$351M
$197K 0.01%
34,269
+22,806
+199% +$162K
LFST icon
1465
Lifestance Health
LFST
$4.15B
$196K 0.01%
+30,807
New +$214K
OPAL icon
1466
OPAL Fuels
OPAL
$68.3M
$192K 0.01%
76,348
+58,035
+317% +$133K
CDXS icon
1467
Codexis
CDXS
$141M
$191K 0.01%
+116,923
New +$167K
RVPH
1468
DELISTED
REVIVA PHARMA HLDGS INC
RVPH
$191K 0.01%
+261,898
New +$1.19M
PATH icon
1469
UiPath
PATH
$6.02B
$189K 0.01%
+17,070
New +$217K
RILY icon
1470
BRC Group Holdings
RILY
$273M
$189K 0.01%
+25,784
New +$192K
CLPR
1471
Clipper Realty
CLPR
$46.4M
$188K 0.01%
62,196
+13,626
+28% +$46K
WBTN
1472
WEBTOON Entertainment Inc
WBTN
$1.25B
$188K 0.01%
+20,434
New +$229K
FTCI icon
1473
FTC Solar
FTCI
$51.2M
$187K 0.01%
49,461
+30,445
+160% +$255K
PRQR icon
1474
ProQR Therapeutics
PRQR
$244M
$185K 0.01%
+114,256
New +$187K
TISI icon
1475
Team
TISI
$77.7M
$185K 0.01%
11,595
-633
-5% -$9.14K

Similar funds

GSA Capital Partners's Q1 2026 Portfolio in Review

As of Q1 2026, GSA Capital Partners held 2,259 positions worth $1.61B, up 39% from $1.16B the previous quarter. Its ten largest holdings account for 12% of the portfolio.

GSA Capital Partners deployed $533M of net new capital in Q1 2026, opening 642 new positions and adding to 549 existing holdings. Its largest new stake was Vanguard Intermediate-Term Corporate Bond ETF: 389,989 shares worth $32.3M.

By sector, the portfolio is most concentrated in Financials at 13% of assets, down from 13% a quarter earlier, followed by Technology and Healthcare.

On the sell side, the largest reduction was NVIDIA, an estimated $4.12M trimmed.

  • GSA Capital Partners's largest Q1 2026 buy was Vanguard Intermediate-Term Corporate Bond ETF: 389,989 shares worth $32.3M.
  • GSA Capital Partners added most to Vanguard Short-Term Corporate Bond ETF in Q1 2026, an estimated $39.8M increase.
  • GSA Capital Partners's biggest Q1 2026 reduction was NVIDIA, cutting an estimated $4.12M.
  • GSA Capital Partners fully exited EOG Resources in Q1 2026, selling an estimated $4.13M.
  • GSA Capital Partners's ten largest holdings make up 12% of its $1.61B portfolio in Q1 2026.
  • GSA Capital Partners opened 642 new positions and closed 595 in Q1 2026.
  • GSA Capital Partners's portfolio value rose 39% quarter-over-quarter to $1.61B.

Based on GSA Capital Partners's 13F filing for Q1 2026, filed 8 May 2026.